News

Gene Therapy in Fanconi Anemia: An Update

Why gene therapy? We know that Fanconi anemia (FA) is caused by defects in any one of 23 different genes called “FANC” genes. If we could somehow repair or replace these defective FANC genes, we could treat or prevent FA...

Read More >

A Pursuit in Genetics

In my early high school days, I noticed that I had a knack for biology, and specifically, genetics. It has always made sense to me and it sparks joy in my life. I know what you’re thinking – very nerdy....

Read More >

Cultivating Wellbeing in Our Lives

Do you feel content and balanced in your life? Do you live with a sense of purpose? Do you find ways to stay energized and connected to your community? Some people may answer yes to those questions, but for many,...

Read More >

Fanconi Anemia Research Fund and NORD Launch Natural History Study of Fanconi Anemia

Research study is open to participants worldwide to advance understanding and treatments for the rare disease Fanconi anemia, diagnosed and confirmed through a combination of clinical findings and genetic analysis Eugene, OR, September 2019 — Today the Fanconi Anemia Research Fund...

Read More >

A gene therapy based clinical trial for Fanconi anemia patients offers its first successful results

*The following is a press release about the recent publication on FA gene therapy in the journal Nature Medicine. This press release was provided by the Center for Energy, Environment and Technology (CIEMAT), the Center for Biomedical Network Research on...

Read More >

Introducing the FAdult Council

In late 2017, for the first time ever, there were more adults living with Fanconi anemia than children living with FA (according to FARF’s registry). This reflects an emerging population of adults living with FA that was not present even...

Read More >